Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/13/04 → 5/31/07 |
Funding
- Procter & Gamble Company: $96,895.00
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Moliterno, David (PI)